Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients
NCT02327676Phase 4Unknown
- Start
- Jan 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of emtricitabine in Chronic Hepatitis B (CHB). Primary endpoint: virological response rate at 48 weeks. Status: unknown.
02
Drugs
emtricitabine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02327676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327676.